Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Excess viscous mucus (adjunct; including chronic obstructive airways disease) renalcarematters.com, reviewed
Kidney dosing: Carbocisteine (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- Usual dose: 2,250 mg/day in divided doses (two 375 mg capsules three times daily), reduced to 1,500 mg/day (one capsule four times daily) once response is achieved (SmPC).
- CrCl 30–59 mL/min
- The SmPC gives no kidney dosing and no kidney pharmacokinetic data. Use with caution and specialist judgment.
- CrCl 15–29 mL/min
- The SmPC gives no kidney dosing and no kidney pharmacokinetic data. Use with caution and specialist judgment.
- CrCl <15 mL/min (not on dialysis)
- The SmPC gives no kidney dosing and no kidney pharmacokinetic data. Use with caution and specialist judgment.
- Hemodialysis (intermittent)
- Not studied in dialysis; no dose given.
- Peritoneal dialysis
- Not studied in dialysis; no dose given.
- CRRT
- Not studied in dialysis; no dose given.
- Dialyzable? Not stated.
- Monitoring Gastrointestinal bleeding, especially in older adults, ulcer history or with drugs that cause bleeding; stop if bleeding occurs (SmPC 4.4).
From the Carbocisteine monograph (renalcarematters.com, reviewed).
Use: INDICATIONS AND USAGE Albuterol Sulfate Syrup is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease. US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Capsule: 2 mg/500 mg
- Suspension: 2 mg/500 mg per 5 mL
Registered products in the Philippines
2 products registered with the Food and Drug Administration (FDA) Philippines list Carbocisteine + Salbutamol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Solmux BronchoSalbutamol + Carbocisteine | 2 mg / 500 mg per 5 mL SuspensionAmber Bottle x 60 mL | Rx | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DRP-14219 | Jan 24, 2030 | |
Solmux BronchoSalbutamol (as sulfate) + Carbocisteine | 2 mg/ 500 mg CapsuleAluminum Foil Strip x 4's (Box of 100's) | Rx | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY678 | May 31, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .